MedPath
NMPA Approval

Azithromycin for Suspension

国药准字H20249662

December 1, 2024

Drug Information

阿奇霉素干混悬剂

口服混悬剂

0.1g(按C₃₈H₇₂N₂O₁₂计)

化学药品

December 1, 2024

Company Information

Applicant Company

威海经技区青岛南路-1-4号

Manufacturing Company

威海市经济技术开发区青岛南路1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

阿奇霉素干混悬剂 - NMPA 批准文号 | MedPath